Wednesday, February 16, 2022

Terray Therapeutics Takes $60M For Chemical Data

Pasadena-based Terray Therapeutics, a startup developing chemical datasets aimed at use in AI-driven small molecule drug discovery, says it has raised $60M in its Series A funding round. The funding was led by Madrona Venture Group, and also included Two Sigma Ventures, Digitalis Ventures, KdT Ventures, Goldcrest Capital, XTX Ventures, Sahsen Ventures, Greentrail Capital and Alexandria Venture Investments. The company had previously raised $20M in a seed funding round from Digitalis Ventures and Two Sigma Ventures. The company is led by CEO Jacob Berlin, Ph.D.